Drug information for PRAZEPAM
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE; ORAL
5MG
Discontinued
PRAZEPAM
Prazepam
USL PHARMA
70427
CAPSULE; ORAL
10MG
Discontinued
PRAZEPAM
Prazepam
USL PHARMA
70428
Drug Adverse Effects information for PRAZEPAM
Role code
Indications
Reaction
# Reports
SS
ANXIETY
CONFUSIONAL STATE
1
SS
ANXIETY
FALL
1
SS
ANXIETY
GAMMA-GLUTAMYLTRANSFERASE INCREASED
1
SS
ANXIETY
HEPATOMEGALY
1
SS
ANXIETY
MULTIPLE DRUG OVERDOSE INTENTIONAL
1
SS
ANXIETY
SUICIDE ATTEMPT
1
SS
ARTHRALGIA
CONFUSIONAL STATE
2
SS
ARTHRALGIA
FALL
2
SS
ASPERGILLOSIS
DISTURBANCE IN ATTENTION
1
SS
ASPERGILLOSIS
RENAL FAILURE ACUTE
1
SS
BRONCHOPULMONARY ASPERGILLOSIS
DISTURBANCE IN ATTENTION
1
SS
BRONCHOPULMONARY ASPERGILLOSIS
RENAL FAILURE ACUTE
1
SS
DEPRESSION
BRADYPHRENIA
2
SS
DEPRESSION
CONFUSIONAL STATE
1
SS
DEPRESSION
DRUG LEVEL INCREASED
3
SS
DEPRESSION
FALL
1
SS
DEPRESSION
FEELING ABNORMAL
2
SS
DEPRESSION
GAMMA-GLUTAMYLTRANSFERASE INCREASED
1
SS
DEPRESSION
HEPATOMEGALY
1
SS
DEPRESSION
INTENTIONAL OVERDOSE
3
SS
DEPRESSION
MOOD ALTERED
3
SS
DEPRESSION
SELF-INJURIOUS IDEATION
2
SS
DEPRESSION
SOCIAL AVOIDANT BEHAVIOUR
1
SS
DEPRESSION
SOPOR
2
SS
FOETAL EXPOSURE DURING PREGNANCY
BLOOD PH INCREASED
2
SS
FOETAL EXPOSURE DURING PREGNANCY
CONGENITAL GENITOURINARY ABNORMALITY
2
SS
FOETAL EXPOSURE DURING PREGNANCY
CONGENITAL INTESTINAL MALFORMATION
2
SS
FOETAL EXPOSURE DURING PREGNANCY
GASTROOESOPHAGEAL REFLUX DISEASE
2
SS
FOETAL EXPOSURE DURING PREGNANCY
MALAISE
2
SS
FOETAL EXPOSURE DURING PREGNANCY
PYELONEPHRITIS
2
SS
FOETAL EXPOSURE DURING PREGNANCY
WITHDRAWAL SYNDROME
2
SS
HYPERTENSION
BRADYPHRENIA
4
SS
HYPERTENSION
DRUG LEVEL INCREASED
4
SS
HYPERTENSION
FEELING ABNORMAL
4
SS
HYPERTENSION
INTENTIONAL OVERDOSE
4
SS
HYPERTENSION
MOOD ALTERED
4
SS
HYPERTENSION
SELF-INJURIOUS IDEATION
4
SS
HYPERTENSION
SOPOR
4
SS
INTENTIONAL OVERDOSE
BRADYPHRENIA
6
SS
INTENTIONAL OVERDOSE
DRUG LEVEL INCREASED
6
SS
INTENTIONAL OVERDOSE
FEELING ABNORMAL
6
SS
INTENTIONAL OVERDOSE
INTENTIONAL OVERDOSE
6
SS
INTENTIONAL OVERDOSE
MOOD ALTERED
6
SS
INTENTIONAL OVERDOSE
SELF-INJURIOUS IDEATION
6
SS
INTENTIONAL OVERDOSE
SOPOR
6
SS
MATERNAL EXPOSURE DURING PREGNANCY
ARNOLD-CHIARI MALFORMATION
6
SS
MATERNAL EXPOSURE DURING PREGNANCY
BLOOD PH INCREASED
2
SS
MATERNAL EXPOSURE DURING PREGNANCY
GASTROOESOPHAGEAL REFLUX DISEASE
2
SS
MATERNAL EXPOSURE DURING PREGNANCY
MALAISE
2
SS
MATERNAL EXPOSURE DURING PREGNANCY
MATERNAL EXPOSURE DURING PREGNANCY
6
SS
MATERNAL EXPOSURE DURING PREGNANCY
MENINGOCELE
6
SS
MATERNAL EXPOSURE DURING PREGNANCY
SPINA BIFIDA
6
SS
MATERNAL EXPOSURE DURING PREGNANCY
WITHDRAWAL SYNDROME
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
BRADYPNOEA
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
CONFUSIONAL STATE
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
CYTOLYTIC HEPATITIS
73
SS
PRODUCT USED FOR UNKNOWN INDICATION
DEPRESSED LEVEL OF CONSCIOUSNESS
73
SS
PRODUCT USED FOR UNKNOWN INDICATION
DISORIENTATION
24
SS
PRODUCT USED FOR UNKNOWN INDICATION
DISTURBANCE IN ATTENTION
16
SS
PRODUCT USED FOR UNKNOWN INDICATION
DRUG LEVEL INCREASED
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
FALL
26
SS
PRODUCT USED FOR UNKNOWN INDICATION
HYPONATRAEMIA
24
SS
PRODUCT USED FOR UNKNOWN INDICATION
HYPOTHERMIA
73
SS
PRODUCT USED FOR UNKNOWN INDICATION
INCORRECT DOSE ADMINISTERED
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
INTENTIONAL DRUG MISUSE
5
SS
PRODUCT USED FOR UNKNOWN INDICATION
INTENTIONAL OVERDOSE
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
MOOD ALTERED
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
MULTIPLE DRUG OVERDOSE INTENTIONAL
83
SS
PRODUCT USED FOR UNKNOWN INDICATION
RENAL FAILURE ACUTE
16
SS
PRODUCT USED FOR UNKNOWN INDICATION
RESPIRATORY ACIDOSIS
73
SS
PRODUCT USED FOR UNKNOWN INDICATION
RESPIRATORY DEPRESSION
72
SS
PRODUCT USED FOR UNKNOWN INDICATION
SELF INJURIOUS BEHAVIOUR
15
SS
PRODUCT USED FOR UNKNOWN INDICATION
SLUGGISHNESS
15
SS
PRODUCT USED FOR UNKNOWN INDICATION
SOCIAL AVOIDANT BEHAVIOUR
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
SOPOR
5
SS
PRODUCT USED FOR UNKNOWN INDICATION
SUICIDE ATTEMPT
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
TOXICITY TO VARIOUS AGENTS
73
SS
TOXICITY TO VARIOUS AGENTS
BRADYPNOEA
4
SS
TOXICITY TO VARIOUS AGENTS
CYTOLYTIC HEPATITIS
4
SS
TOXICITY TO VARIOUS AGENTS
DEPRESSED LEVEL OF CONSCIOUSNESS
4
SS
TOXICITY TO VARIOUS AGENTS
HYPOTHERMIA
4
SS
TOXICITY TO VARIOUS AGENTS
INCORRECT DOSE ADMINISTERED
4
SS
TOXICITY TO VARIOUS AGENTS
RESPIRATORY ACIDOSIS
4
SS
TOXICITY TO VARIOUS AGENTS
TOXICITY TO VARIOUS AGENTS
4
SS
TYPE 2 DIABETES MELLITUS
BRADYPHRENIA
2
SS
TYPE 2 DIABETES MELLITUS
CONFUSIONAL STATE
1
SS
TYPE 2 DIABETES MELLITUS
DRUG LEVEL INCREASED
2
SS
TYPE 2 DIABETES MELLITUS
FALL
1
SS
TYPE 2 DIABETES MELLITUS
FEELING ABNORMAL
2
SS
TYPE 2 DIABETES MELLITUS
INTENTIONAL OVERDOSE
2
SS
TYPE 2 DIABETES MELLITUS
MOOD ALTERED
2
SS
TYPE 2 DIABETES MELLITUS
SELF-INJURIOUS IDEATION
2
SS
TYPE 2 DIABETES MELLITUS
SOPOR
2
C
ABSTAINS FROM ALCOHOL
DEATH
4
C
ANALGESIC THERAPY
ANAPHYLACTIC SHOCK
1
C
ANTACID THERAPY
DRY SKIN
1
C
ANTACID THERAPY
PSORIASIS
1
C
ANTIVIRAL TREATMENT
DRY SKIN
1
C
ANTIVIRAL TREATMENT
PSORIASIS
1
C
ANXIETY
AGGRESSION
1
C
ANXIETY
BIPOLAR I DISORDER
1
C
ANXIETY
C-REACTIVE PROTEIN INCREASED
2
C
ANXIETY
DEATH
4
C
ANXIETY
DEPRESSION
6
C
ANXIETY
GLOMERULONEPHROPATHY
2
C
ANXIETY
HAEMATURIA
2
C
ANXIETY
HYPOALBUMINAEMIA
2
C
ANXIETY
NEPHROTIC SYNDROME
2
C
ANXIETY
OBSESSIVE-COMPULSIVE DISORDER
6
C
ANXIETY
PANCREATITIS ACUTE
2
C
ANXIETY
PROTEINURIA
2
C
ANXIETY
PRURITUS GENERALISED
1
C
ANXIETY
PSYCHOTIC DISORDER
2
C
ANXIETY
RASH
1
C
ANXIETY
RENAL FAILURE ACUTE
2
C
ANXIETY
WHITE BLOOD CELL COUNT INCREASED
2
C
ANXIOLYTIC THERAPY
DRY SKIN
1
C
ANXIOLYTIC THERAPY
PSORIASIS
1
C
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
BRONCHOSPASM
1
C
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
PULMONARY CONGESTION
1
C
COLITIS
C-REACTIVE PROTEIN INCREASED
2
C
COLITIS
GLOMERULONEPHROPATHY
2
C
COLITIS
HAEMATURIA
2
C
COLITIS
HYPOALBUMINAEMIA
2
C
COLITIS
NEPHROTIC SYNDROME
2
C
COLITIS
PANCREATITIS ACUTE
2
C
COLITIS
PROTEINURIA
2
C
COLITIS
RENAL FAILURE ACUTE
2
C
COLITIS
WHITE BLOOD CELL COUNT INCREASED
2
C
DEPRESSED MOOD
AGITATION
1
C
DEPRESSED MOOD
ANXIETY
1
C
DEPRESSED MOOD
COAGULOPATHY
1
C
DEPRESSED MOOD
DEPRESSED MOOD
1
C
DEPRESSED MOOD
INTENTIONAL DRUG MISUSE
1
C
DEPRESSED MOOD
PULMONARY EMBOLISM
2
C
DEPRESSED MOOD
WRONG TECHNIQUE IN DRUG USAGE PROCESS
1
C
DEPRESSION
DEPRESSION
6
C
DEPRESSION
OBSESSIVE-COMPULSIVE DISORDER
6
C
DYSLIPIDAEMIA
ALANINE AMINOTRANSFERASE INCREASED
1
C
DYSLIPIDAEMIA
ASPARTATE AMINOTRANSFERASE INCREASED
1
C
DYSLIPIDAEMIA
GAMMA-GLUTAMYLTRANSFERASE INCREASED
1
C
DYSLIPIDAEMIA
LIPASE INCREASED
1
C
DYSLIPIDAEMIA
PYREXIA
1
C
EPILEPSY
C-REACTIVE PROTEIN INCREASED
2
C
EPILEPSY
GLOMERULONEPHROPATHY
2
C
EPILEPSY
HAEMATURIA
2
C
EPILEPSY
HYPOALBUMINAEMIA
2
C
EPILEPSY
NEPHROTIC SYNDROME
2
C
EPILEPSY
PANCREATITIS ACUTE
2
C
EPILEPSY
PROTEINURIA
2
C
EPILEPSY
RENAL FAILURE ACUTE
2
C
EPILEPSY
WHITE BLOOD CELL COUNT INCREASED
2
C
HEART TRANSPLANT
CYTOMEGALOVIRUS INFECTION
3
C
HEART TRANSPLANT
LUNG DISORDER
3
C
HEART TRANSPLANT
LYMPHOEDEMA
3
C
HEART TRANSPLANT
OEDEMA PERIPHERAL
3
C
HEART TRANSPLANT
WEIGHT INCREASED
3
C
HEPATITIS C
AGGRESSION
3
C
HEPATITIS C
CHEST PAIN
9
C
HEPATITIS C
EPISTAXIS
9
C
HEPATITIS C
HEADACHE
9
C
HEPATITIS C
MUSCULAR WEAKNESS
9
C
HEPATITIS C
RASH
3
C
HEPATITIS C
VISION BLURRED
3
C
HIV INFECTION
DEATH
4
C
HYPERCHOLESTEROLAEMIA
AGITATION
1
C
HYPERCHOLESTEROLAEMIA
ANXIETY
1
C
HYPERCHOLESTEROLAEMIA
COAGULOPATHY
1
C
HYPERCHOLESTEROLAEMIA
DEPRESSED MOOD
1
C
HYPERCHOLESTEROLAEMIA
PULMONARY EMBOLISM
1
C
HYPERCHOLESTEROLAEMIA
WRONG TECHNIQUE IN DRUG USAGE PROCESS
1
C
HYPERTENSION
ALANINE AMINOTRANSFERASE INCREASED
1
C
HYPERTENSION
ASPARTATE AMINOTRANSFERASE INCREASED
1
C
HYPERTENSION
DECREASED APPETITE
1
C
HYPERTENSION
DRY SKIN
1
C
HYPERTENSION
FALL
1
C
HYPERTENSION
GAMMA-GLUTAMYLTRANSFERASE INCREASED
1
C
HYPERTENSION
GENERAL PHYSICAL HEALTH DETERIORATION
1
C
HYPERTENSION
HAEMODIALYSIS
1
C
HYPERTENSION
HYPERKALAEMIA
1
C
HYPERTENSION
KIDNEY SMALL
1
C
HYPERTENSION
LIPASE INCREASED
1
C
HYPERTENSION
METABOLIC ACIDOSIS
1
C
HYPERTENSION
PSORIASIS
1
C
HYPERTENSION
PYREXIA
1
C
HYPERTENSION
RENAL DISORDER
1
C
HYPERTENSION
RENAL FAILURE ACUTE
1
C
IMPULSE-CONTROL DISORDER
ABNORMAL BEHAVIOUR
1
C
IMPULSE-CONTROL DISORDER
ANXIETY
1
C
IMPULSE-CONTROL DISORDER
AUTONOMIC NERVOUS SYSTEM IMBALANCE
1
C
IMPULSE-CONTROL DISORDER
DEPRESSION
1
C
IMPULSE-CONTROL DISORDER
DRUG INEFFECTIVE
1
C
IMPULSE-CONTROL DISORDER
FATIGUE
1
C
IMPULSE-CONTROL DISORDER
LETHARGY
1
C
IMPULSE-CONTROL DISORDER
SOMNOLENCE
1
C
IMPULSE-CONTROL DISORDER
WEIGHT INCREASED
1
C
IMPULSE-CONTROL DISORDER
WHITE BLOOD CELL COUNT DECREASED
1
C
INFLUENZA LIKE ILLNESS
CHEST PAIN
3
C
INFLUENZA LIKE ILLNESS
EPISTAXIS
3
C
INFLUENZA LIKE ILLNESS
HEADACHE
3
C
INFLUENZA LIKE ILLNESS
MUSCULAR WEAKNESS
3
C
INFLUENZA LIKE ILLNESS
VISION BLURRED
1
C
INSOMNIA
CHEST PAIN
3
C
INSOMNIA
EPISTAXIS
3
C
INSOMNIA
HEADACHE
3
C
INSOMNIA
MUSCULAR WEAKNESS
3
C
INSOMNIA
VISION BLURRED
1
C
LUNG ADENOCARCINOMA
APHASIA
1
C
LUNG ADENOCARCINOMA
MEMORY IMPAIRMENT
1
C
LUNG ADENOCARCINOMA
REVERSIBLE ISCHAEMIC NEUROLOGICAL DEFICIT
1
C
LUNG ADENOCARCINOMA
VISUAL FIELD DEFECT
1
C
LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0
APHASIA
1
C
LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0
MEMORY IMPAIRMENT
1
C
LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0
REVERSIBLE ISCHAEMIC NEUROLOGICAL DEFICIT
1
C
LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0
VISUAL FIELD DEFECT
1
C
LUNG NEOPLASM MALIGNANT
C-REACTIVE PROTEIN INCREASED
2
C
LUNG NEOPLASM MALIGNANT
GLOMERULONEPHROPATHY
2
C
LUNG NEOPLASM MALIGNANT
HAEMATURIA
2
C
LUNG NEOPLASM MALIGNANT
HYPOALBUMINAEMIA
2
C
LUNG NEOPLASM MALIGNANT
NEPHROTIC SYNDROME
2
C
LUNG NEOPLASM MALIGNANT
PANCREATITIS ACUTE
2
C
LUNG NEOPLASM MALIGNANT
PROTEINURIA
2
C
LUNG NEOPLASM MALIGNANT
RENAL FAILURE ACUTE
2
C
LUNG NEOPLASM MALIGNANT
REVERSIBLE ISCHAEMIC NEUROLOGICAL DEFICIT
1
C
LUNG NEOPLASM MALIGNANT
WHITE BLOOD CELL COUNT INCREASED
2
C
LYMPHOCYTIC LYMPHOMA
BLOOD DISORDER
1
C
LYMPHOCYTIC LYMPHOMA
DEAFNESS
1
C
LYMPHOCYTIC LYMPHOMA
PYREXIA
1
C
LYMPHOCYTIC LYMPHOMA
TINNITUS
1
C
LYMPHOCYTIC LYMPHOMA
TOXIC SKIN ERUPTION
1
C
MAJOR DEPRESSION
MYOCARDIAL INFARCTION
3
C
MULTIPLE SCLEROSIS
DEPRESSION
2
C
MULTIPLE SCLEROSIS
OBSESSIVE-COMPULSIVE DISORDER
2
C
NERVOUSNESS
CHEST PAIN
6
C
NERVOUSNESS
EPISTAXIS
6
C
NERVOUSNESS
HEADACHE
6
C
NERVOUSNESS
MUSCULAR WEAKNESS
6
C
NERVOUSNESS
VISION BLURRED
2
C
NON-SMALL CELL LUNG CANCER
REVERSIBLE ISCHAEMIC NEUROLOGICAL DEFICIT
1
C
OSTEOARTHRITIS
DECREASED APPETITE
1
C
OSTEOARTHRITIS
FALL
1
C
OSTEOARTHRITIS
GENERAL PHYSICAL HEALTH DETERIORATION
1
C
OSTEOARTHRITIS
HAEMODIALYSIS
1
C
OSTEOARTHRITIS
HYPERKALAEMIA
1
C
OSTEOARTHRITIS
KIDNEY SMALL
1
C
OSTEOARTHRITIS
METABOLIC ACIDOSIS
1
C
OSTEOARTHRITIS
RENAL DISORDER
1
C
OSTEOARTHRITIS
RENAL FAILURE ACUTE
1
C
PARKINSON'S DISEASE
ABNORMAL BEHAVIOUR
9
C
PARKINSON'S DISEASE
AGITATION
9
C
PARKINSON'S DISEASE
AKINESIA
9
C
PARKINSON'S DISEASE
AMIMIA
9
C
PARKINSON'S DISEASE
BACK PAIN
9
C
PARKINSON'S DISEASE
BALANCE DISORDER
9
C
PARKINSON'S DISEASE
C-REACTIVE PROTEIN INCREASED
9
C
PARKINSON'S DISEASE
CHROMATURIA
9
C
PARKINSON'S DISEASE
COMPULSIVE SHOPPING
9
C
PARKINSON'S DISEASE
CORNEAL REFLEX DECREASED
9
C
PARKINSON'S DISEASE
DEPRESSED MOOD
9
C
PARKINSON'S DISEASE
DEPRESSION
9
C
PARKINSON'S DISEASE
DYSPNOEA
9
C
PARKINSON'S DISEASE
DYSTHYMIC DISORDER
9
C
PARKINSON'S DISEASE
FALL
9
C
PARKINSON'S DISEASE
HYPOMANIA
9
C
PARKINSON'S DISEASE
IRRITABILITY
9
C
PARKINSON'S DISEASE
MUSCLE RIGIDITY
9
C
PARKINSON'S DISEASE
MUSCLE SPASMS
9
C
PARKINSON'S DISEASE
MUSCULOSKELETAL PAIN
9
C
PARKINSON'S DISEASE
NECK PAIN
9
C
PARKINSON'S DISEASE
NEUROSIS
9
C
PARKINSON'S DISEASE
PSYCHOMOTOR HYPERACTIVITY
9
C
PARKINSON'S DISEASE
PSYCHOTIC BEHAVIOUR
9
C
PARKINSON'S DISEASE
RED BLOOD CELL SEDIMENTATION RATE INCREASED
9
C
PARKINSON'S DISEASE
SUICIDAL IDEATION
9
C
PARKINSON'S DISEASE
SUICIDE ATTEMPT
9
C
PARKINSON'S DISEASE
THYMUS DISORDER
9
C
PARKINSON'S DISEASE
TREMOR
9
C
PARKINSON'S DISEASE
WEIGHT INCREASED
9
C
PLATELET AGGREGATION INHIBITION
DRY SKIN
1
C
PLATELET AGGREGATION INHIBITION
PSORIASIS
1
C
PLEURAL MESOTHELIOMA
BLOOD DISORDER
3
C
PLEURAL MESOTHELIOMA
DEAFNESS
3
C
PLEURAL MESOTHELIOMA
PYREXIA
3
C
PLEURAL MESOTHELIOMA
TINNITUS
3
C
PLEURAL MESOTHELIOMA
TOXIC SKIN ERUPTION
3
C
PREMEDICATION
BLOOD DISORDER
5
C
PREMEDICATION
DEAFNESS
5
C
PREMEDICATION
PYREXIA
5
C
PREMEDICATION
TINNITUS
5
C
PREMEDICATION
TOXIC SKIN ERUPTION
5
C
PRODUCT USED FOR UNKNOWN INDICATION
APHASIA
5
C
PRODUCT USED FOR UNKNOWN INDICATION
DECREASED APPETITE
5
C
PRODUCT USED FOR UNKNOWN INDICATION
DEMENTIA
5
C
PRODUCT USED FOR UNKNOWN INDICATION
DIET REFUSAL
5
C
PRODUCT USED FOR UNKNOWN INDICATION
DISTURBANCE IN ATTENTION
5
C
PRODUCT USED FOR UNKNOWN INDICATION
DRUG LEVEL INCREASED
5
C
PRODUCT USED FOR UNKNOWN INDICATION
FAILURE TO THRIVE
5
C
PRODUCT USED FOR UNKNOWN INDICATION
MYOCLONUS
4
C
PRODUCT USED FOR UNKNOWN INDICATION
RENAL FAILURE ACUTE
5
C
PRODUCT USED FOR UNKNOWN INDICATION
SOMNOLENCE
5
C
PROPHYLAXIS
ANAPHYLACTIC SHOCK
1
C
PROPHYLAXIS AGAINST HIV INFECTION
CARPAL TUNNEL SYNDROME
2
C
PROPHYLAXIS AGAINST HIV INFECTION
DIARRHOEA
1
C
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
DRY SKIN
3
C
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
PSORIASIS
3
C
PSORIASIS
BIPOLAR I DISORDER
1
C
PSORIASIS
PRURITUS GENERALISED
1
C
PSORIASIS
PSYCHOTIC DISORDER
2
C
SCHIZOPHRENIA
DELUSION OF REFERENCE
1
C
SCHIZOPHRENIA
SUICIDAL IDEATION
1
C
SCHIZOPHRENIA
TRISMUS
1
C
SLEEP DISORDER
AGITATION
1
C
SLEEP DISORDER
ANXIETY
1
C
SLEEP DISORDER
COAGULOPATHY
1
C
SLEEP DISORDER
DEPRESSED MOOD
1
C
SLEEP DISORDER
INTENTIONAL DRUG MISUSE
1
C
SLEEP DISORDER
PULMONARY EMBOLISM
2
C
SLEEP DISORDER
WRONG TECHNIQUE IN DRUG USAGE PROCESS
1
C
SMOKING CESSATION THERAPY
DEATH
16
C
TONSILLITIS
MYOCLONUS
2
C
TUBERCULOSIS
BIPOLAR I DISORDER
1
C
TUBERCULOSIS
PRURITUS GENERALISED
1
C
TUBERCULOSIS
PSYCHOTIC DISORDER
2
C
TYPE 2 DIABETES MELLITUS
ALANINE AMINOTRANSFERASE INCREASED
4
C
TYPE 2 DIABETES MELLITUS
ASPARTATE AMINOTRANSFERASE INCREASED
4
C
TYPE 2 DIABETES MELLITUS
GAMMA-GLUTAMYLTRANSFERASE INCREASED
4
C
TYPE 2 DIABETES MELLITUS
LIPASE INCREASED
4
C
TYPE 2 DIABETES MELLITUS
PYREXIA
4
Ads by Google